Perfuse Therapeutics is Drug Discovery in United States that focus on proliferative diabetic retinopathy business. Founded in 2018. They cover business area such as operator, retinal perfusion, various retinal disease, doctor, glaucoma, non-proliferative diabetic retinopathy, retinal vein occlusion.
2018
( 6 years old in 2024 )
Proliferative Diabetic Retinopathy
-
1700 Owens Street
Suite 540
San Francisco, CA 94158
United States
Private
operatorretinal perfusionvarious retinal diseasedoctorglaucomanon-proliferative diabetic retinopathyretinal vein occlusion
* We use standard office opening hours in near Perfuse Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Perfuse Therapeutics is Drug Discovery business from United States that founded in 2018 (6 years old in 2024), Perfuse Therapeutics business is focusing on Proliferative Diabetic Retinopathy.
Perfuse Therapeutics headquarter office and corporate office address is located in 1700 Owens Street Suite 540 San Francisco, CA 94158 United States.
Perfuse Therapeutics was founded in United States.
In 2024, Perfuse Therapeutics is currently focus on proliferative diabetic retinopathy sector.
Above is snippet of Google Trends for "proliferative diabetic retinopathy" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Perfuse Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
